Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men

  • Rosell Díaz, Marisel
  • Petit Gay, Anna
  • Molas Prat, Clàudia
  • Gallardo Nuell, Laura
  • Ramió Torrentà, Lluís
  • Garre Olmo, Josep
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Bäckhed, Fredrik
  • Mayneris Perxachs, Jordi
  • Fernández Real, José Manuel
Background : An altered gut microbiome characterized by reduced abundance of butyrate producing bacteria and reduced gene richness is associated with type 2 diabetes (T2D). An important complication of T2D is increased risk of cognitive impairment and dementia. The biguanide metformin is a commonly prescribed medication for the control of T2D and metformin treatment has been associated with a significant reduction in the risk of dementia and improved cognition, particularly in people with T2D. Aim : To investigate the associations of metformin use with cognition exploring potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively. Methods : We explored two independent cohorts: an observational study (Aging Imageomics) and a phase IV, randomized, double-blind, parallel-group, randomized pilot study (MEIFLO). From the two studies, we analyzed four study groups: (1) individuals with no documented medical history or medical treatment (n = 172); (2) people with long-term T2D on metformin monotherapy (n = 134); (3) people with long-term T2D treated with oral hypoglycemic agents other than metformin (n = 45); (4) a newly diagnosed T2D subjects on metformin monotherapy (n = 22). Analyses were also performed stratifying by sex. Results : Several bacterial species belonging to the Proteobacteria (Escherichia coli) and Verrucomicrobia (Akkermansia muciniphila) phyla were positively associated with metformin treatment, while bacterial species belonging to the Firmicutes phylum (Romboutsia timonensis, Romboutsia ilealis) were negatively associated. Due to the consistent increase in A. muciniphila and decrease in R.ilealis in people with T2D subjects treated with metformin, we investigated the association between this ratio and cognition. In the entire cohort of metformin-treated T2D subjects, the A.muciniphila/R.ilealis ratio was not significantly associated with cognitive test scores. However, after stratifying by sex, the A.muciniphila/R. ilealis ratio was significantly and positively associated with higher memory scores and improved memory in men. Metformin treatment was associated with an enrichment of microbial pathways involved in the TCA cycle, and butanoate, arginine, and proline metabolism in both cohorts. The bacterial genes involved in arginine metabolism, especially in production of glutamate (astA, astB, astC, astD, astE, putA), were enriched following metformin intake. In agreement, in the metabolomics analysis, metformin treatment was strongly associated with the amino acid proline, a metabolite involved in the metabolism of glutamate. Conclusions : The beneficial effects of metformin may be mediated by changes in the composition of the gut microbiota and microbial-host-derived co-metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934 and PI21/ 01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska- Curie Innovative Training Network grant agreement No 859890. Open Access funding provided by the CRUE-CSIC agreement with Elsevier. The Aging Imageomics Study has been funded by Pla estrat`egic de recerca i innovaci´o en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/00250). IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. is a ‘Serra-Hunter’ Fellow. J.M.- P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Union under the European Social Fund “Investing in your future”). J.M.-P. was also supported through the project CNS2023-144218 funded by MICIU/ AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men

  • Rosell Díaz, Marisel
  • Petit Gay, Anna
  • Molas Prat, Clàudia
  • Gallardo Nuell, Laura
  • Ramió Torrentà, Lluís
  • Garre Olmo, Josep
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Bäckhed, Fredrik
  • Mayneris Perxachs, Jordi
  • Fernández Real, José Manuel
Background : An altered gut microbiome characterized by reduced abundance of butyrate producing bacteria and reduced gene richness is associated with type 2 diabetes (T2D). An important complication of T2D is increased risk of cognitive impairment and dementia. The biguanide metformin is a commonly prescribed medication for the control of T2D and metformin treatment has been associated with a significant reduction in the risk of dementia and improved cognition, particularly in people with T2D. Aim : To investigate the associations of metformin use with cognition exploring potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively. Methods : We explored two independent cohorts: an observational study (Aging Imageomics) and a phase IV, randomized, double-blind, parallel-group, randomized pilot study (MEIFLO). From the two studies, we analyzed four study groups: (1) individuals with no documented medical history or medical treatment (n = 172); (2) people with long-term T2D on metformin monotherapy (n = 134); (3) people with long-term T2D treated with oral hypoglycemic agents other than metformin (n = 45); (4) a newly diagnosed T2D subjects on metformin monotherapy (n = 22). Analyses were also performed stratifying by sex. Results : Several bacterial species belonging to the Proteobacteria (Escherichia coli) and Verrucomicrobia (Akkermansia muciniphila) phyla were positively associated with metformin treatment, while bacterial species belonging to the Firmicutes phylum (Romboutsia timonensis, Romboutsia ilealis) were negatively associated. Due to the consistent increase in A. muciniphila and decrease in R.ilealis in people with T2D subjects treated with metformin, we investigated the association between this ratio and cognition. In the entire cohort of metformin-treated T2D subjects, the A.muciniphila/R.ilealis ratio was not significantly associated with cognitive test scores. However, after stratifying by sex, the A.muciniphila/R. ilealis ratio was significantly and positively associated with higher memory scores and improved memory in men. Metformin treatment was associated with an enrichment of microbial pathways involved in the TCA cycle, and butanoate, arginine, and proline metabolism in both cohorts. The bacterial genes involved in arginine metabolism, especially in production of glutamate (astA, astB, astC, astD, astE, putA), were enriched following metformin intake. In agreement, in the metabolomics analysis, metformin treatment was strongly associated with the amino acid proline, a metabolite involved in the metabolism of glutamate. Conclusions : The beneficial effects of metformin may be mediated by changes in the composition of the gut microbiota and microbial-host-derived co-metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934 and PI21/ 01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska- Curie Innovative Training Network grant agreement No 859890. Open Access funding provided by the CRUE-CSIC agreement with Elsevier. The Aging Imageomics Study has been funded by Pla estrat`egic de recerca i innovaci´o en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/00250). IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. is a ‘Serra-Hunter’ Fellow. J.M.- P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Union under the European Social Fund “Investing in your future”). J.M.-P. was also supported through the project CNS2023-144218 funded by MICIU/ AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased brain fractional perfusion in obesity using intravoxel incoherent motion (IVIM) MRI metrics

  • Motger Albertí, Anna|||0000-0002-9430-371X
  • de la Calle, Elena
  • Giménez, Mònica
  • Blasco, Gerard|||0000-0002-5302-0625
  • Biarnés, Carles|||0000-0002-6604-2014
  • Arnoriaga-Rodriguez, Maria|||0000-0002-0394-1223
  • Puig, Josep|||0000-0003-2791-6599
  • Coll-Martínez, Clàudia|||0000-0003-2927-4008
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
Objective: This research seeks to shed light on the associations between brain perfusion, cognitive function, and mental health in individuals with and without obesity. Methods: In this study, we employed the noninvasive intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) technique to examine brain fractional perfusion (FP) in two groups: individuals with obesity (N = 72) and healthy controls (N = 66). Additionally, we investigated potential associations between FP, cognitive function, and depressive symptoms in the participants with and without obesity. Finally, artificial intelligence algorithms (Boruta analysis) were also used. Results: Participants with obesity exhibited increased FP within dopaminergic brain circuits, particularly involving prefrontal cortex areas, anterior and posterior sections of the cingulate cortex, the right striatum, and the midbrain. Additionally, these individuals demonstrated lower working memory and higher depressive symptoms compared to the control group. Notably, higher FP in the inferior temporal and occipital cortices correlated with greater depressive symptoms, whereas increased FP in the right ventral caudate and the midbrain was associated with better working memory performance. A link between inflammatory and metabolic variables, with a particular emphasis on monocytes, and FP in obesity was also evidenced by Boruta analysis. Conclusions: Increased brain perfusion in individuals with obesity is associated with cognitive function and mental health through interaction with metabolic and inflammatory factors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lower serum ferritin levels are associated with worse cognitive performance in aging

  • Rosell-Díaz, Marisel|||0000-0001-7599-6584
  • Santos-González, Elena
  • Motger Albertí, Anna|||0000-0002-9430-371X
  • Gallardo-Nuell, Laura
  • Arnoriaga-Rodriguez, Maria|||0000-0002-0394-1223
  • Coll-Martínez, Clàudia|||0000-0003-2927-4008
  • Ramió-Torrentà, Lluís|||0000-0002-6999-1004
  • Garre-Olmo, Josep|||0000-0002-7817-0814
  • Puig, Josep|||0000-0003-2791-6599
  • Ramos, Rafel|||0000-0001-7970-5537
  • Mayneris-Perxachs, Jordi|||0000-0003-3788-3815
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
Objectives: Iron is important for neurogenesis, synaptic development, and neurotransmitter synthesis. Serum ferritin (SF) is a reliable marker for assessing iron stores. Therefore, we evaluated the cognitive function associated with SF levels. We also assessed brain iron content using R2* Magnetic Resonance Imaging (MRI) and its association with SF levels. Design: Data from three cross-sectional observational studies were used. Aging Imageomics (n = 1030) was conducted on aged subjects. Health Imageomics (n = 971) and IR0NMET (n = 175) were conducted in middle-aged subjects. Setting and participants: Participants were enrolled at Dr. Josep Trueta University Hospital facilities. The three cohorts included a total of 2176 subjects (mean age, 52 years; 48% men). Measurements: SF levels were measured by standard laboratory methods. Total Digits Span (TDS), and Phonemic Verbal Fluency (PVF) were used to assess executive function. Language function was assessed by semantic verbal fluency (SVF), attention by the Symbol Digit Modalities Test, and memory by the Memory Binding Tests - Total Free Recall and Total Delayed Free Recall. MRI was used to assess the iron content of the brain by R2*. Results: In subjects aged 65 years or older, SF levels were associated with increased TDS (β = 0.003, p = 0.02), PVF (β = 0.004, p = 0.01), and SVF (β = 0.004, p = 0.002) scores. After stratification by sex, these findings were significant only in men, where SF was associated with increased TDS (β = 0.003, p = 0.01), PVF (β = 0.004, p = 0.03), and SVF (β = 0.004, p = 0.009) scores. In middle-aged subjects, SF was also associated with increased SVF scores (β = 0.005, p = 0.011). Lastly, in men, SF levels were negatively associated with R2*, a surrogate marker of brain iron content, in both the left frontal inferior opercular area (r = -0.41, p = 0.005) and the right frontal inferior opercular area (r = -0.44, p = 0.002). Conclusions: SF is significantly and positively associated with cognition. In older people with low SF levels, iron supplementation may be a promising therapy to improve cognition.